ft 13 mar 93 london stock exchang fda hit drug blue chip fund manag specialis health household sector alreadi reel week two dose bad news affect glaxo drug market former glamour stock given anoth thorough shake smithklin beecham sb share fell sharpli bad news us us food drug administr fda advisori committe reject approv sb kytril formul anti nausea drug cite concern side effect pharmaceut specialist describ reject approv kytrin big disappoint said move signific knock confid stock said kytrin one hand key new drug sb also point fda move seen market delay rather total reject anoth bear point sb share articl british medic journal highlight review anti depress drug favour exist prepar newer drug includ sb paxil sb share heavili support week big intern fund switch glaxo sb tumbl 466p steadi close net 21 1 2 469 1 2 p turnov ordinari total hefti 6 2m share overal market declin yet sell pressur us put paid hope reviv glaxo share dip 656p stabilis settl net 3 665p